Skip to main content
OpenTrials
Completed

NCT Number: NCT04503421

Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal Biceps Tendon Repair

The goal of this investigation is to determine if using BFR during postoperative therapy would lead to increased and expedited strength gains. Additionally, the investigators would like to determine if BFR is beneficial in preventing muscle atrophy and fatty infiltration in the setting of bicep tendon tears, due to the altered tension-length relationship following surgery. The study will also look at patient reported outcomes metrics and pain scores to determine if BFR has a significant impact on the patient experience surrounding distal biceps tear and surgical repair

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Health Ford Health System

Detroit, Michigan, 48202, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-80
  • Undergoing distal biceps tendon repair

Exclusion criteria

  • Revision Biceps tendon repair,
  • Irrepairable tendon injury,
  • Biceps repairs with biologic augmentation,
  • Patients with concomitant neurovascular injury,
  • Inability to tolerate BFR treatment,
  • Unable to complete full course of physical therapy,
  • Peripheral vascular disease,
  • History of Venous thromboembolism (VTE)

Treatment and study plan

Blood Flow Restriction Therapy

Other

Use of a tourniquet set to 50% of limb occlusion pressure while performing post operative physical therapy

Primary outcomes

  1. Strength

    Time frame: 1 week post-operatively

    measured via dynamometer (pounds)

  2. Strength

    Time frame: 6 weeks post-operatively

    measured via dynamometer (pounds)

  3. Strength

    Time frame: 3 months post-operatively

    measured via dynamometer (pounds)

  4. Strength

    Time frame: 6 months post-operatively

    measured via dynamometer (pounds)

Secondary outcomes

  1. Range of Motion

    Time frame: 1 week post-operatively

    via goniometer (degrees)

  2. Range of Motion

    Time frame: 6 week post-operatively

    via goniometer (degrees)

  3. Range of Motion

    Time frame: 3 months post-operatively

    via goniometer (degrees)

  4. Range of Motion

    Time frame: 6 months post-operatively

    via goniometer (degrees)

  5. Perceived Pain

    Time frame: 1 week post-operatively

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

  6. Perceived Pain

    Time frame: 6 week post-operatively

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

  7. Perceived Pain

    Time frame: 3 months post-operatively

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

  8. Perceived Pain

    Time frame: 6 months post-operatively

    via visual analog scale (VAS) pain scale: (scale 0 - 10, higher score indicates more pain)

  9. Patient reported outcome scores

    Time frame: 1 week post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

  10. Patient reported outcome scores

    Time frame: 1 week post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

  11. Patient reported outcome scores

    Time frame: 1 week post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

  12. Patient reported outcome scores

    Time frame: 6 week post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

  13. Patient reported outcome scores

    Time frame: 6 week post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

  14. Patient reported outcome scores

    Time frame: 6 week post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

  15. Patient reported outcome scores

    Time frame: 3 months post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

  16. Patient reported outcome scores

    Time frame: 3 months post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

  17. Patient reported outcome scores

    Time frame: 3 months post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

  18. Patient reported outcome scores

    Time frame: 6 months post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function (PF) score

  19. Patient reported outcome scores

    Time frame: 6 months post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Pain (P) score

  20. Patient reported outcome scores

    Time frame: 6 months post-operatively

    via Patient-Reported Outcomes Measurement Information System (PROMIS) Depression (D) score

Sponsors and collaborators

Lead sponsor

Henry Ford Health System

Other

Registry information

Official study title

Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal: A Prospective Randomized Control Trial

Important dates

Study start
2020
Primary completion
2021
Study completion
2021
First posted
Aug 7, 2020
Registry last updated
Dec 8, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.